The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| LLBO | +400% | -73.68% | -23.41% | -100% |
| S&P | +13.95% | +78.35% | +12.25% | +536% |
Lifeline Biotechnologies, Inc. engages in the development and marketing of technology, applications, and medical devices. It is involved in the development of The First Warning System for assisting in the early detection of breast cancer. The company was founded by William Reeves in 1994 and is headquartered in Reno, NV.
No news articles found for Lifeline Biotechnologies.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00K | 0.0% |
| Gross Profit | $0.00K | 0.0% |
| Market Cap | $3.91M | 125.0% |
| Market Cap / Employee | $3.91M | 0.0% |
| Employees | 1 | 0.0% |
| Net Income | -$30.09K | 0.0% |
| EBITDA | -$30.09K | 0.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $0.00K | 0.0% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00K | 0.0% |
| Short Term Debt | $0.00K | 0.0% |
| Current | YOY Change | |
|---|---|---|
| Return On Invested Capital | 10.79% | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $0.00K | 0.0% |
| Operating Free Cash Flow | $0.00K | 0.0% |
| Metric | Q3 2025 | YoY Change | |||
|---|---|---|---|---|---|
| Price to Book | -45.00 | - | |||
| Price to Tangible Book Value | -50.78 | - | |||
| Enterprise Value to EBITDA | -90.62 | -362.46 | -16.87 | -130.08 | - |
| Total Debt | $0.00K | $0.00K | $0.00K | $0.00K | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
